Hypercholesterolaemia

4 trials 1 recruiting MedDRA PT
4 Registered trials
1 Recruiting
3 Unique sponsors
1 Unique IMPs
3 Commercial trials
Drug classes (ATC)
— ATC code not specified 4
Mechanism of action (INN-stem analysis)
Unknown / small molecule 1 substance
Phase II: 1 Phase IV: 1 Phase I: 1 Phase I (Other): 1

Filter these 4 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 4 trials

Phase II

1 trial
  • Esperion Therapeutics Inc. Commercial
    BEMPEDOIC ACID
    2024-515864-30-00 4 countries 2025 n=27
    Ended

Phase IV

1 trial
  • Fundacion Para La Investigacion Biomedica Del Hospital Universitario La Paz Academic
    IMP not specified
    2023-506814-31-01 1 country 2024 n=1,000
    Recruiting

Phase I

1 trial
  • Merck Sharp & Dohme LLC Commercial
    IMP not specified
    2024-516016-17-00 1 country 2024 n=32
    Ended

Phase I (Other)

1 trial
  • Merck Sharp & Dohme LLC Commercial
    IMP not specified
    2025-524852-74-00 1 country 2026 n=32
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Merck Sharp & Dohme LLC Commercial 2 Phase I, Phase I (Other) 0
Esperion Therapeutics Inc. Commercial 1 Phase II 0
Fundacion Para La Investigacion Biomedica Del Hospital Universitario La Paz Academic 1 Phase IV 1
New trials by year
2024
2
2025
1
2026
1
← All indication landscapes